Aequus Pharmaceuticals Inc. a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced today that is has filed a Clinical Trial Application (“CTA”) with Health Canada in preparation for a Proof of Concept clinical study for its long-acting transdermal anti-nausea patch, AQS1303, containing the combination of pyridoxine and doxylamine (the active ingredients in Diclegis®/Diclectin®). Upon approval…
Read More
With Canada’s fast-growing tech sector facing a shortage of 220,000 workers by 2020, the federal government is right to expedite the immigration process for highly skilled workers with its new Global Talent Stream, launched June 12. As one of the CEOs from across the country who called on Ottawa to streamline the immigration process so that Canadian high-growth companies could quickly access talent in addition…
Read More
AbCellera has entered into a collaborative research effort with Sanofi Pasteur, a global leader in the development and sale of vaccines for seasonal influenza. The project will use AbCellera’s single-cell screening platform to profile vaccine-specific human antibodies elicited by seasonal influenza vaccination and to generate large panels of human monoclonal antibodies with desired binding profiles to various influenza strains. Carl…
Read More
Prof. Jim Kronstad was honoured on Thursday May 4th in a celebration commemorating his 9 years as the MSL Director. In the words of his predecessor, Prof. Phil Hieter, the event was for a man “with a lot of honour and integrity”. These heartfelt sentiments resonated throughout the afternoon as Prof. Kronstad received praise for his creativity, wisdom, strength, hard-working…
Read More
“In theory, cerebral edema is a very simple issue; it’s the movement of water from the blood into the brain by osmosis, causing brain swelling. When water is drawn into nerve cells, the brain expands in the skull and that’s where you see severe complications from stroke or traumatic brain injury,” explains Dr. Nick Weilinger. “My work in the MacVicar…
Read More

For Banting Scholar Dr. Brianne Kent, Research Is All about Rhythm

“The great thing about working with both patients and pre-clinical models is that the research truly is translational,” says Dr. Brianne Kent. “Understanding patients with Alzheimer disease helps me to ask the right questions, better inform study design, and delve into the mechanisms of the disease in a holistic way.” Dr. Kent, already a Killam Laureate and Michael Smith Foundation…
Read More
“If there is one thing we have to keep doing, it is explaining and making the case for research – of all types: basic and applied,” David Naylor, former University of Toronto president, told the packed room. He was addressing 200 of the nation’s scientists and researchers who had gathered last week at Metro Toronto Convention Centre to discuss the…
Read More
How do pathogenic bacteria manipulate host cells and cause disease? What molecular structures allow them to accomplish such feats? Here, at the Centre for Blood Research, Dr Natalie Strynadka’s laboratory and colleagues have used cryo-electron microscopy (cryo-EM) to visualize molecular details of the “nano-syringe” Salmonella uses to inject virulence proteins into eukaryotic host cells and cause disease. Their findings have…
Read More
Today Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus”) a specialty pharmaceutical company with expertise in drug delivery and clinical development, and the Centre For Drug Research and Development (“CDRD”), Canada’s national drug development and commercialization centre, announced a broad research collaboration to establish pre-clinical safety and efficacy of select cannabinoid-based therapeutics targeting neurological movement disorders including epilepsy, Multiple Sclerosis,…
Read More